Raia Drogasil (Raia Drogasil) Debt-to-Revenue : 0.19 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Raia Drogasil's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $240 Mil. Raia Drogasil's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1,155 Mil. Raia Drogasil's annualized Revenue for the quarter that ended in Mar. 2024 was $7,310 Mil. Raia Drogasil's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.19.

Raia Drogasil Debt-to-Revenue Historical Data

The historical data trend for Raia Drogasil's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Debt-to-Revenue Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.25

0.22

0.21

Raia Drogasil Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial															0.19	0.19	0.20	0.20	0.19

Competitive Comparison of Raia Drogasil's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Debt-to-Revenue falls into.

Raia Drogasil Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Raia Drogasil's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(298.597	+	1143.801)	/	6933.71
	=	0.21

Raia Drogasil's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(240.007	+	1155.487)	/	7309.928
	=	0.19

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

Raia Drogasil Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (Raia Drogasil) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

RADL3:Brazil

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.